The EHR Dark Data Goldmine: Why Sentence-Level Provenance Is Pharma's New Real-World Evidence Moat
Dr. Dereck Mush, MD, MBA
ConcertAI
Provides real-world data and AI software solutions for oncology clinical development.
What they do
ConcertAI provides real-world data, AI technologies, and advanced analytics software for oncology and life sciences. The company partners with healthcare providers and pharmaceutical companies to accelerate clinical trials, generate real-world evidence, and improve patient outcomes through precise data insights.
The record
- Vertical
- Oncology
- Sub-segment
- Real-world data and analytics
- Product type
- Platform software
- Stage
- Growth
- Headquarters
- Cambridge, United States
- Region
- North America
- Founded
- 2017
- Total funding
- $300M raised
Notable investors: Romulus Capital, Declaration Partners, SymphonyAI Group.
Also in Oncology
Related on The Signal
Dr. Dereck Mush, MD, MBA
How Much Weight Does Real-World Evidence Actually Carry at FDA?
Dr. Dereck Mush, MD, MBA
The GLP-1 Data Nobody Puts in the Deck: Adherence, Regain and What Payers Now Model
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
She Lost 60 Pounds on Ozempic. Then Her Insurance Stopped Covering It.
She Lost 60 Pounds on Ozempic. Then Her Insurance Stopped Covering It.
Dr. Dereck Mush, MD, MBA